SILICON·LIFE
About Silicon Life

Founded where medicine meets engineering

Silicon Life was founded in Wuhan in 2023, with Tongji Hospital and the Wuhan Industrial Innovation and Development Research Institute among its strategic shareholders.

Medical-device engineering laboratory

Company profile

Wuhan Guiji Shengming Medical Technology Co., Ltd. develops devices for urology and artificial organs. Its clinical starting point is the bladder: restoring lost bladder function today, and replacing the organ in the future. Its first product, the Disposable Sterile Controlled Catheter, is registered in China as a Class II medical device for female patients with voiding dysfunction.

The same team works across the whole path from clinical need and basic research to engineering and production. It is developing implantable systems, including an electronically controlled artificial bladder, on in-house work in wireless power, flexible sensing and on-device signal recognition.

Of 41 employees, 32% work in research and development, including one postdoctoral researcher and four PhDs. The company has completed a Pre-A financing round of RMB 64 million.

Founded
November 2023
Headquarters
Wuhan, Hubei, China
Strategic shareholders
Tongji Hospital and the Wuhan Industrial Innovation and Development Research Institute
Focus
Urology and artificial organs
Marketed
1 device, registered in China
Pipeline
6 programmes in development
Team
41 people · 32% in R&D
Patents
8 granted · 18 pending
Vision

To bring artificial organs into real clinical use.

让人工器官真正走向临床应用

PrincipleScience first, patients at the centre.

Leadership

Management team

Portrait of Ling Qing, PhD

Ling Qing, PhD凌青

Founder & Chairman

Founder of Silicon Life and a named inventor on its artificial-bladder and controllable-catheter patent families.

Portrait of Wang Jing

Wang Jing王靖

General Manager

Responsible for the overall management of the company.

Portrait of Ma Wenxiang

Ma Wenxiang马文香

Deputy General Manager

Supports the general manager in running the company.

Portrait of Wu Youlin

Wu Youlin吴有林

Director of Research & Development

Leads research and development across the catheter platform and implantable programmes.

Recognition

Honours and awards

  • 2026
    Most Investment & Incubation Value Award
    Programme: BCI electronic artificial bladder
    Optics Valley Qingtonghui, Wuhan
  • 2025
    First Prize, Innovation & Entrepreneurship Competition
    Programme: BCI electronic artificial bladder
    China Medical Device Network
  • 2024
    Top 10 Medicine–Engineering Innovation Achievements of Hubei Province
    Programme: Magnetically controlled artificial bladder
    Hubei Province
  • 2024
    Technology-based SME and Wuhan Innovative SME
    Government designations
  • —
    Winner, Disruptive Technology Innovation Competition
    Programme: Magnetically controlled artificial bladder
    Ministry of Science and Technology of the PRC
  • —
    Original Exploration Programme funding
    Programme: Magnetically controlled artificial bladder
    National Natural Science Foundation of China
Intellectual property

Patent portfolio

Silicon Life holds 8 granted patents and software copyrights, with 18 further applications pending. Core inventions are filed in China first; the female-catheter family is extended internationally.

Priority filing
CN
Inventions are filed first with the China National Intellectual Property Administration.
International
PCT
An international application under the Patent Cooperation Treaty for the female-catheter family.
National filings
USFRJP
Filings in the United States, France and Japan for the same family, including a granted US patent.
Patent families by jurisdiction and filing status
#Patent familyCNPCTUSFRJP
01Female catheter and structural componentsCatheter platformChina: Application filedPatent Cooperation Treaty: Application filedUnited States: GrantedFrance: Application filedJapan: Application filed
02Male catheterCatheter platformChina: GrantedPatent Cooperation Treaty: Not filedUnited States: Not filedFrance: Not filedJapan: Not filed
03Catheter with controllable urinationCatheter platformChina: Application filedPatent Cooperation Treaty: Not filedUnited States: Not filedFrance: Not filedJapan: Not filed
04Anti-dislodgement urinary drainage deviceCatheter platformChina: Application filedPatent Cooperation Treaty: Not filedUnited States: Not filedFrance: Not filedJapan: Not filed
05Artificial-bladder ferromagnetic composite and preparation methodArtificial organsChina: GrantedPatent Cooperation Treaty: Not filedUnited States: Not filedFrance: Not filedJapan: Not filed
06Thermoforming method for an implantable flexible magnetic bladder pumpArtificial organsChina: GrantedPatent Cooperation Treaty: Not filedUnited States: Not filedFrance: Not filedJapan: Not filed
07Wireless electromagnetically controlled urination systemArtificial organsChina: Application filedPatent Cooperation Treaty: Not filedUnited States: Not filedFrance: Not filedJapan: Not filed
08Urination device and system with electromagnetic valveArtificial organsChina: Application filedPatent Cooperation Treaty: Not filedUnited States: Not filedFrance: Not filedJapan: Not filed
GrantedApplication filedNot filedStatus as of September 2026; source: company patent register.
Research

Peer-reviewed publications

Selected papers by the founding team at Tongji Hospital and Huazhong University of Science and Technology. Preclinical findings do not establish safety or effectiveness in people.